Literature DB >> 9701680

Predicting survival in patients with early Alzheimer's disease.

J J Claus1, W A van Gool, S Teunisse, G J Walstra, V I Kwa, A Hijdra, B Verbeeten, J H Koelman, L J Bour, B W Ongerboer De Visser.   

Abstract

We investigated whether an index based on clinical features, electroencephalogram and computed tomography is useful to predict survival in early Alzheimer's disease. One hundred and sixty-three consecutively referred patients to an outpatient memory clinic and first diagnosed with Alzheimer's disease (105 'probable' and 58 'possible', NINCDS-ADRDA criteria) were studied and outcome measure was death. Cox proportional hazards regression analysis and Kaplan-Meier survival curves were used to investigate relations between baseline parameters and survival. Eighty-four patients (51. 5%) died during the follow-up period that extended to 5.8 years, with a median duration of survival after entry of 4.3 years. Baseline factors that were statistically significant and independently related to increased risk of mortality were high age, male sex, poor cognitive function as measured with the CAMCOG, low alpha and beta power on electroencephalogram, and temporoparietal atrophy on computed tomography scan. These results were independent of the diagnosis probable or possible Alzheimer's disease. Based on the coefficients from the regression equation, we computed a survival index for each patient and we constructed three groups according to tertiles of this index. After 5.2 years of follow-up, survival curves showed a low mortality group with 81.7% patients alive (median survival at least 5.7 years), an intermediate mortality group with 35.9% patients alive (median survival 3.8 years), and a high mortality group with no patients alive (median survival 2.3 years). Log rank tests were statistically significant for comparisons between all three groups. We conclude that an overall index combining demographic, cognitive, electroencephalogram and computed tomography features is a strong predictor of survival in early Alzheimer's disease.

Entities:  

Mesh:

Year:  1998        PMID: 9701680     DOI: 10.1159/000017073

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  12 in total

1.  Factors affecting survival of patients with neurodegenerative disease.

Authors:  Kyle Steenland; Jessica MacNeil; Ryan Seals; Allan Levey
Journal:  Neuroepidemiology       Date:  2010-04-08       Impact factor: 3.282

2.  A population-based study on the influence of brain atrophy on 20-year survival after age 85.

Authors:  P J Olesen; X Guo; D Gustafson; A Börjesson-Hanson; S Sacuíu; C Eckerström; E D Bigler; I Skoog
Journal:  Neurology       Date:  2011-03-08       Impact factor: 9.910

3.  The effects of counseling spouse caregivers of people with Alzheimer disease taking donepezil and of country of residence on rates of admission to nursing homes and mortality.

Authors:  Henry Brodaty; Mary Mittelman; Louisa Gibson; Katrin Seeher; Alistair Burns
Journal:  Am J Geriatr Psychiatry       Date:  2009-09       Impact factor: 4.105

4.  Mediterranean diet and Alzheimer disease mortality.

Authors:  Nikolaos Scarmeas; Jose A Luchsinger; Richard Mayeux; Yaakov Stern
Journal:  Neurology       Date:  2007-09-11       Impact factor: 9.910

5.  Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.

Authors:  Colin Green; Shenqiu Zhang
Journal:  Alzheimers Dement       Date:  2016-03-24       Impact factor: 21.566

6.  Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition?

Authors:  Dena B Dubal; Lauren Broestl; Kurtresha Worden
Journal:  Biol Sex Differ       Date:  2012-11-05       Impact factor: 5.027

7.  10 Hz flicker improves recognition memory in older people.

Authors:  Jonathan Williams; Deepa Ramaswamy; Abderrahim Oulhaj
Journal:  BMC Neurosci       Date:  2006-03-05       Impact factor: 3.288

8.  Index of alpha/theta ratio of the electroencephalogram: a new marker for Alzheimer's disease.

Authors:  Magali T Schmidt; Paulo A M Kanda; Luis F H Basile; Helder Frederico da Silva Lopes; Regina Baratho; Jose L C Demario; Mario S Jorge; Antonio E Nardi; Sergio Machado; Jéssica N Ianof; Ricardo Nitrini; Renato Anghinah
Journal:  Front Aging Neurosci       Date:  2013-10-09       Impact factor: 5.750

9.  Factors determining disease duration in Alzheimer's disease: a postmortem study of 103 cases using the Kaplan-Meier estimator and Cox regression.

Authors:  R A Armstrong
Journal:  Biomed Res Int       Date:  2014-01-22       Impact factor: 3.411

10.  Disease-related determinants are associated with mortality in dementia due to Alzheimer's disease.

Authors:  Hanneke F M Rhodius-Meester; Hilkka Liedes; Ted Koene; Afina W Lemstra; Charlotte E Teunissen; Frederik Barkhof; Philip Scheltens; Mark van Gils; Jyrki Lötjönen; Wiesje M van der Flier
Journal:  Alzheimers Res Ther       Date:  2018-02-20       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.